Atb Cap Markets Estimates Ascend Wellness Q1 Earnings

Ascend Wellness Holdings, Inc. (OTC:AAWHFree Report) – Equities research analysts at Atb Cap Markets issued their Q1 2025 EPS estimates for Ascend Wellness in a research report issued to clients and investors on Thursday, March 13th. Atb Cap Markets analyst F. Gomes forecasts that the company will post earnings of ($0.07) per share for the quarter. The consensus estimate for Ascend Wellness’ current full-year earnings is ($0.40) per share. Atb Cap Markets also issued estimates for Ascend Wellness’ Q2 2025 earnings at ($0.07) EPS, Q3 2025 earnings at ($0.06) EPS, Q4 2025 earnings at ($0.05) EPS, FY2025 earnings at ($0.25) EPS, FY2026 earnings at ($0.14) EPS, FY2027 earnings at ($0.12) EPS and FY2028 earnings at ($0.11) EPS.

Ascend Wellness Trading Up 1.6 %

Shares of Ascend Wellness stock opened at $0.33 on Monday. The stock has a market cap of $69.69 million, a PE ratio of -0.79 and a beta of 1.27. The firm has a 50-day moving average of $0.38 and a 200-day moving average of $0.57. Ascend Wellness has a 52-week low of $0.27 and a 52-week high of $1.55. The company has a debt-to-equity ratio of 2.61, a quick ratio of 0.80 and a current ratio of 1.47.

About Ascend Wellness

(Get Free Report)

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.

Read More

Earnings History and Estimates for Ascend Wellness (OTC:AAWH)

Receive News & Ratings for Ascend Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascend Wellness and related companies with MarketBeat.com's FREE daily email newsletter.